Preliminary Third Quarter 2013 Revenue Results in Advance of Attendance at the 28th Annual North American Spine Society (NASS) Meeting in New Orleans, Louisiana Continuing Execution Propels Alphatec to Strong Third Quarter Global Growth CARLSBAD, Calif., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced its top line financial results for the third quarter of fiscal year 2013, ended September 30, 2013. Third Quarter Revenue Highlights include: *Third quarter 2013 total revenue is approximately $50.1 million; up approximately 7.0% from the third quarter of 2012, or approximately 10.0% on a constant currency basis, representing broad growth in all of our markets. *U.S. revenue of approximately $33.7 million; up approximately 8.8% from the third quarter of 2012. Positive performance in the U.S. was the result of continued solid unit volume gains in our core hospital business and increased surgeon uptake across our various product lines. *International revenue is approximately $16.4 million; up approximately 3.4% from the third quarter of 2012, or approximately 13.0% on a constant currency basis. Strong operational performance was again attributable to the Company's robust business in Japan combined with thriving underlying demand in Latin America, Asia and Europe. Alphatec Spine expects to file a more detailed press release regarding its third quarter 2013 results on Form 8-K as well as filing its Form 10-Q for the three months ended September 30, 2013 on November 7, 2013, with an accompanying investor call to follow shortly thereafter. About Alphatec Spine Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a medical device company that designs, develops, manufactures and markets physician-inspired products and solutions for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration. The Company's mission is to combine innovative surgical solutions with world-class customer service to improve outcomes and patient quality of life. The Company and its affiliates market products in the U.S. and in over 50 countries internationally via a direct sales force and independent distributors. Additional information can be found at www.alphatecspine.com. Forward Looking Statements This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward looking statements include references to Alphatec Spine's 2013 revenue (including without limitation, the approximated revenues for Q3 2013 that are set forth in this press release) and adjusted EBITDA projections; the success of the Company's initiatives to drive global sales growth, increase margins and increase operating efficiencies. The words "believe," "will," "should," "expect," "intend," "estimate," "anticipate," and "approximately" and variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including its Annual Report Form 10-K for the year ended December 31, 2012, filed on March 4, 2013 with the Securities and Exchange Commission, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law. CONTACT: Investor/Media Contact: Christine Zedelmayer Investor Relations Alphatec Spine, Inc. (760) 494-6610 email@example.com Alphatec Spine
Preliminary Third Quarter 2013 Revenue Results in Advance of Attendance at the 28th Annual North American Spine Society (NASS)
Press spacebar to pause and continue. Press esc to stop.